Table 7.

Methods for separation of target material and purification and formulation of [⁶⁸Ga]GaCl₃.

Process	Method	Result	Ref.
Separation of target material and purification, and formulation	Platform: FastLab2 Developer, GE Healthcare, Wisconsin, USA Purification: Zr Resin washed with 0.1 M HNO3 (9 mL), elute with 2 M HCl (5 mL) Formulation: TK200, elute with 0.1 N HCl (5 mL)	EOS = 2.3 ± 0.2 GBq	[35]
	Platform: Trasis All-in-One, Belgium Purification: 100 mg, hydroxamate resin (50–100 μm); washed with of 0.005 M HNO3 (50 mL); elute with of 5.5 M HCl (7 mL). Formulation: 400 mg, AG-1X-8 anion exchange resin; elution with 2 mL of water.	NR	[36]
	Platform: FastLab2 Developer, GE Healthcare, Milwaukee, WI, USA Purification: Zr Resin; condition with 0.1 M HNO3 (7 mL); washed with 0.1 M HNO3 (15 mL), elution with 1.75 M HCl (5–6 mL). Formulation: TK200 resin; condition with water (7 mL) followed by 1.75 M HCl (4 mL) before use; washed with 2.0 M NaCl (3.5 mL) in 0.13 M HCl; elute with 1–2 mL H2O followed by dilute HCl to formulate	EOS= 2.0  ±  0.3 GBq 50 mCi	[37]